About IntroDia®

The challenge of Type 2 Diabetes
  • As an HCP, you'll recognise that successful management of T2D requires a holistic approach1




  • But while effective medication is available, without the right lifestyle changes, T2D treatment is not as successful as it could be...


    Currently, just 50% of T2D patients are controlled
    If we could help more patients make the right lifestyle changes, this number might move a lot closer 100%...

  • So, IntroDia® asked:

    How could we improve the way we manage T2D and support patients in changing their lifestyles?

Could what we say to our patients make a difference?

  • 1. Inzucchi SE,et al.Diabetes Care 2012;35:1364-79.
  • 2. Wallace TM, et al Q J Med 2000;93:369-74.
  • 3. Delamater AM, Clin Diabetes 2006;24(2):71-77.
  • 4. Del Parto S, et al. Int J Clin Pract 2005;59(11):1345-55.


IntroDia® assessed how the early T2D conversations influence patient outcomes

IntroDia® is the largest quantitative study of its kind











See all participating countries
  • Argentina
  • Australia
  • Austria
  • Brazil
  • Bulgaria
  • Canada
  • China
  • Denmark
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Mexico
  • The Netherlands
  • Norway
  • Philippines
  • Russia
  • Saudia Arabia
  • South Africa
  • South Korea
  • Spain
  • UAE
  • UK
  • USA

What are early conversations?

The early conversations take place at two critical moments in the T2D patient journey
Insulin and other treatment options

Why early conversations?

Effective patient-physician conversations are known to lead to better outcomes in T2D1

    Adherence to medication2


    Good physician communication has been independently associated with a predicted 18% improvement in adherence to medication as compared to poor communication


    Self-care activities3


    Explaining key self-care activities to patients has been shown to more than double the likelihood that the behavior would be implemented


    HbA1c control1


    Diabetes-specific patient-physician communication has been found to be a significant determinant of HbA1c control (p=0.033)

  1. Aikens JE, et al. Diabetes Educ 2005:31(5):681-90.
  2. Piette JD, et al. J Gen Intern Med 2003;18:624-633.
  3. Bundesmann R, et al. Patient Educ Couns 2011;85:143-147.

IntroDia® Design

Design block one


How was IntroDia® conducted?

IntroDia® was conducted in two ways

Face-to-face interviews

Online questionnaires

Design block two


What were patients asked?

1 - What did they recall hearing during their early T2D conversations

Examples of recalled statements*

* Patients were provided with a list of 20+ statements on which to report

2 - Their self-reported health status

Healthy diet



Overall well-being

Diabetes-related distress

Health status was assessed using 7 validated scales

Design block three


How were the results analyzed?

The relationship between the recalled statements and self-reported patient outcomes was assessed through a complex analysis

By understanding the effect of different statements on patient outcomes, IntroDia® will optimize the early T2D conversations.

The people behind IntroDia®

IntroDia® has been developed in colloboration with an advisory board of international T2D experts

The IntroDia® Advisory Board :


Dr Steven Edelman
Ms. Su Down
Nurse Consultant in Diabetes
Dr. Aus Alzaid
Saudi Arabia
Dr. William Polonsky
Behavioral Psychologist
Dr. Matthew
Primary Care Physician
As one of the contributors, I was delighted to join my colleagues to discuss the crucial conversations that we, as healthcare professionals, have with people living with type 2 diabetes. These early conversations play a big part in setting the scene for a person’s lifetime with their condition.
Our discussions, and subsequently the report published, underline the need to really get these moments right and the challenges we need to tackle in order to do so.
Ms. Anne Belton
Diabetes Nurse Educator, Former Vice President of the International Diabetes Federation
In partnership with

IntroDia® Activities to date

Select a country on the map or using the menu on the right

JavaScript chart by amCharts 3.20.12

Select an event

  • Australia
  • Austria
  • Canada
  • China
  • France
  • South Korea
  • Sweden
  • United Kingdom
  • United States

About Introdia®

  • The challenge of Type 2 Diabetes
  • IntroDia® assessed how the early T2D conversations influence patient outcomes
  • What are early ConversatIons?
  • Why early conversations?
  • IntroDia® Design
  • The people behind IntroDia®
  • IntroDia® Activities to date